Global Liposomal Drug Delivery Device Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Liposomal Drug Delivery Device market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Liposomal Drug Delivery Device market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Liposomal Drug Delivery Device market size and forecasts, in consumption value ($ Million), 2018-2029
Global Liposomal Drug Delivery Device market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Liposomal Drug Delivery Device market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Liposomal Drug Delivery Device market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liposomal Drug Delivery Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liposomal Drug Delivery Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Luye Pharma Group, Ipsen Pharma, Celsion, Inc. and Galen Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Liposomal Drug Delivery Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Liposomal Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liposomal Drug Delivery Device, with revenue, gross margin and global market share of Liposomal Drug Delivery Device from 2018 to 2023.
Chapter 3, the Liposomal Drug Delivery Device competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Liposomal Drug Delivery Device market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Liposomal Drug Delivery Device.
Chapter 13, to describe Liposomal Drug Delivery Device research findings and conclusion.
This report is a detailed and comprehensive analysis for global Liposomal Drug Delivery Device market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Liposomal Drug Delivery Device market size and forecasts, in consumption value ($ Million), 2018-2029
Global Liposomal Drug Delivery Device market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Liposomal Drug Delivery Device market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Liposomal Drug Delivery Device market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liposomal Drug Delivery Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liposomal Drug Delivery Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Luye Pharma Group, Ipsen Pharma, Celsion, Inc. and Galen Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Liposomal Drug Delivery Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Stealth Liposome Technology
- NonPEGylated Liposome Technology
- DepoFoam Liposome Technology
- Fungal Diseases
- Cancer Therapy
- Pain Management
- Viral Vaccines
- Photodynamic Therapy
- Novartis AG
- Luye Pharma Group
- Ipsen Pharma
- Celsion, Inc.
- Galen Limited
- Astellas Pharma, Inc.
- Acrotech Biopharma, Inc.
- Fudan-Zhangjiang
- Pacira
- Creative Biolabs
- Precision NanoSystems Inc.
- Encapsula NanoSciences LLC
- Avanti Polar Lipids, Inc.
- Viatris Inc.
- Merrimack Pharmaceuticals, Inc
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Liposomal Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liposomal Drug Delivery Device, with revenue, gross margin and global market share of Liposomal Drug Delivery Device from 2018 to 2023.
Chapter 3, the Liposomal Drug Delivery Device competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Liposomal Drug Delivery Device market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Liposomal Drug Delivery Device.
Chapter 13, to describe Liposomal Drug Delivery Device research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Liposomal Drug Delivery Device
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liposomal Drug Delivery Device by Type
1.3.1 Overview: Global Liposomal Drug Delivery Device Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Liposomal Drug Delivery Device Consumption Value Market Share by Type in 2022
1.3.3 Stealth Liposome Technology
1.3.4 NonPEGylated Liposome Technology
1.3.5 DepoFoam Liposome Technology
1.4 Global Liposomal Drug Delivery Device Market by Application
1.4.1 Overview: Global Liposomal Drug Delivery Device Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Fungal Diseases
1.4.3 Cancer Therapy
1.4.4 Pain Management
1.4.5 Viral Vaccines
1.4.6 Photodynamic Therapy
1.5 Global Liposomal Drug Delivery Device Market Size & Forecast
1.6 Global Liposomal Drug Delivery Device Market Size and Forecast by Region
1.6.1 Global Liposomal Drug Delivery Device Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Liposomal Drug Delivery Device Market Size by Region, (2018-2029)
1.6.3 North America Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.4 Europe Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.6 South America Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Liposomal Drug Delivery Device Product and Solutions
2.1.4 Novartis AG Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Luye Pharma Group
2.2.1 Luye Pharma Group Details
2.2.2 Luye Pharma Group Major Business
2.2.3 Luye Pharma Group Liposomal Drug Delivery Device Product and Solutions
2.2.4 Luye Pharma Group Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Luye Pharma Group Recent Developments and Future Plans
2.3 Ipsen Pharma
2.3.1 Ipsen Pharma Details
2.3.2 Ipsen Pharma Major Business
2.3.3 Ipsen Pharma Liposomal Drug Delivery Device Product and Solutions
2.3.4 Ipsen Pharma Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ipsen Pharma Recent Developments and Future Plans
2.4 Celsion, Inc.
2.4.1 Celsion, Inc. Details
2.4.2 Celsion, Inc. Major Business
2.4.3 Celsion, Inc. Liposomal Drug Delivery Device Product and Solutions
2.4.4 Celsion, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Celsion, Inc. Recent Developments and Future Plans
2.5 Galen Limited
2.5.1 Galen Limited Details
2.5.2 Galen Limited Major Business
2.5.3 Galen Limited Liposomal Drug Delivery Device Product and Solutions
2.5.4 Galen Limited Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Galen Limited Recent Developments and Future Plans
2.6 Astellas Pharma, Inc.
2.6.1 Astellas Pharma, Inc. Details
2.6.2 Astellas Pharma, Inc. Major Business
2.6.3 Astellas Pharma, Inc. Liposomal Drug Delivery Device Product and Solutions
2.6.4 Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Astellas Pharma, Inc. Recent Developments and Future Plans
2.7 Acrotech Biopharma, Inc.
2.7.1 Acrotech Biopharma, Inc. Details
2.7.2 Acrotech Biopharma, Inc. Major Business
2.7.3 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product and Solutions
2.7.4 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Acrotech Biopharma, Inc. Recent Developments and Future Plans
2.8 Fudan-Zhangjiang
2.8.1 Fudan-Zhangjiang Details
2.8.2 Fudan-Zhangjiang Major Business
2.8.3 Fudan-Zhangjiang Liposomal Drug Delivery Device Product and Solutions
2.8.4 Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fudan-Zhangjiang Recent Developments and Future Plans
2.9 Pacira
2.9.1 Pacira Details
2.9.2 Pacira Major Business
2.9.3 Pacira Liposomal Drug Delivery Device Product and Solutions
2.9.4 Pacira Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pacira Recent Developments and Future Plans
2.10 Creative Biolabs
2.10.1 Creative Biolabs Details
2.10.2 Creative Biolabs Major Business
2.10.3 Creative Biolabs Liposomal Drug Delivery Device Product and Solutions
2.10.4 Creative Biolabs Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Creative Biolabs Recent Developments and Future Plans
2.11 Precision NanoSystems Inc.
2.11.1 Precision NanoSystems Inc. Details
2.11.2 Precision NanoSystems Inc. Major Business
2.11.3 Precision NanoSystems Inc. Liposomal Drug Delivery Device Product and Solutions
2.11.4 Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Precision NanoSystems Inc. Recent Developments and Future Plans
2.12 Encapsula NanoSciences LLC
2.12.1 Encapsula NanoSciences LLC Details
2.12.2 Encapsula NanoSciences LLC Major Business
2.12.3 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product and Solutions
2.12.4 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Encapsula NanoSciences LLC Recent Developments and Future Plans
2.13 Avanti Polar Lipids, Inc.
2.13.1 Avanti Polar Lipids, Inc. Details
2.13.2 Avanti Polar Lipids, Inc. Major Business
2.13.3 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product and Solutions
2.13.4 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Avanti Polar Lipids, Inc. Recent Developments and Future Plans
2.14 Viatris Inc.
2.14.1 Viatris Inc. Details
2.14.2 Viatris Inc. Major Business
2.14.3 Viatris Inc. Liposomal Drug Delivery Device Product and Solutions
2.14.4 Viatris Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Viatris Inc. Recent Developments and Future Plans
2.15 Merrimack Pharmaceuticals, Inc
2.15.1 Merrimack Pharmaceuticals, Inc Details
2.15.2 Merrimack Pharmaceuticals, Inc Major Business
2.15.3 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product and Solutions
2.15.4 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Merrimack Pharmaceuticals, Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liposomal Drug Delivery Device Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Liposomal Drug Delivery Device by Company Revenue
3.2.2 Top 3 Liposomal Drug Delivery Device Players Market Share in 2022
3.2.3 Top 6 Liposomal Drug Delivery Device Players Market Share in 2022
3.3 Liposomal Drug Delivery Device Market: Overall Company Footprint Analysis
3.3.1 Liposomal Drug Delivery Device Market: Region Footprint
3.3.2 Liposomal Drug Delivery Device Market: Company Product Type Footprint
3.3.3 Liposomal Drug Delivery Device Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liposomal Drug Delivery Device Consumption Value and Market Share by Type (2018-2023)
4.2 Global Liposomal Drug Delivery Device Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2023)
5.2 Global Liposomal Drug Delivery Device Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
6.2 North America Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
6.3 North America Liposomal Drug Delivery Device Market Size by Country
6.3.1 North America Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
6.3.2 United States Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
6.3.3 Canada Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
6.3.4 Mexico Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
7.2 Europe Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
7.3 Europe Liposomal Drug Delivery Device Market Size by Country
7.3.1 Europe Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
7.3.2 Germany Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.3 France Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.5 Russia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.6 Italy Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Liposomal Drug Delivery Device Market Size by Region
8.3.1 Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Region (2018-2029)
8.3.2 China Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.3 Japan Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.4 South Korea Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.5 India Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.7 Australia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
9.2 South America Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
9.3 South America Liposomal Drug Delivery Device Market Size by Country
9.3.1 South America Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
9.3.2 Brazil Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
9.3.3 Argentina Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Liposomal Drug Delivery Device Market Size by Country
10.3.1 Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
10.3.2 Turkey Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
10.3.4 UAE Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Liposomal Drug Delivery Device Market Drivers
11.2 Liposomal Drug Delivery Device Market Restraints
11.3 Liposomal Drug Delivery Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Liposomal Drug Delivery Device Industry Chain
12.2 Liposomal Drug Delivery Device Upstream Analysis
12.3 Liposomal Drug Delivery Device Midstream Analysis
12.4 Liposomal Drug Delivery Device Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Liposomal Drug Delivery Device
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liposomal Drug Delivery Device by Type
1.3.1 Overview: Global Liposomal Drug Delivery Device Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Liposomal Drug Delivery Device Consumption Value Market Share by Type in 2022
1.3.3 Stealth Liposome Technology
1.3.4 NonPEGylated Liposome Technology
1.3.5 DepoFoam Liposome Technology
1.4 Global Liposomal Drug Delivery Device Market by Application
1.4.1 Overview: Global Liposomal Drug Delivery Device Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Fungal Diseases
1.4.3 Cancer Therapy
1.4.4 Pain Management
1.4.5 Viral Vaccines
1.4.6 Photodynamic Therapy
1.5 Global Liposomal Drug Delivery Device Market Size & Forecast
1.6 Global Liposomal Drug Delivery Device Market Size and Forecast by Region
1.6.1 Global Liposomal Drug Delivery Device Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Liposomal Drug Delivery Device Market Size by Region, (2018-2029)
1.6.3 North America Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.4 Europe Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.6 South America Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Liposomal Drug Delivery Device Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Liposomal Drug Delivery Device Product and Solutions
2.1.4 Novartis AG Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments and Future Plans
2.2 Luye Pharma Group
2.2.1 Luye Pharma Group Details
2.2.2 Luye Pharma Group Major Business
2.2.3 Luye Pharma Group Liposomal Drug Delivery Device Product and Solutions
2.2.4 Luye Pharma Group Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Luye Pharma Group Recent Developments and Future Plans
2.3 Ipsen Pharma
2.3.1 Ipsen Pharma Details
2.3.2 Ipsen Pharma Major Business
2.3.3 Ipsen Pharma Liposomal Drug Delivery Device Product and Solutions
2.3.4 Ipsen Pharma Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ipsen Pharma Recent Developments and Future Plans
2.4 Celsion, Inc.
2.4.1 Celsion, Inc. Details
2.4.2 Celsion, Inc. Major Business
2.4.3 Celsion, Inc. Liposomal Drug Delivery Device Product and Solutions
2.4.4 Celsion, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Celsion, Inc. Recent Developments and Future Plans
2.5 Galen Limited
2.5.1 Galen Limited Details
2.5.2 Galen Limited Major Business
2.5.3 Galen Limited Liposomal Drug Delivery Device Product and Solutions
2.5.4 Galen Limited Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Galen Limited Recent Developments and Future Plans
2.6 Astellas Pharma, Inc.
2.6.1 Astellas Pharma, Inc. Details
2.6.2 Astellas Pharma, Inc. Major Business
2.6.3 Astellas Pharma, Inc. Liposomal Drug Delivery Device Product and Solutions
2.6.4 Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Astellas Pharma, Inc. Recent Developments and Future Plans
2.7 Acrotech Biopharma, Inc.
2.7.1 Acrotech Biopharma, Inc. Details
2.7.2 Acrotech Biopharma, Inc. Major Business
2.7.3 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product and Solutions
2.7.4 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Acrotech Biopharma, Inc. Recent Developments and Future Plans
2.8 Fudan-Zhangjiang
2.8.1 Fudan-Zhangjiang Details
2.8.2 Fudan-Zhangjiang Major Business
2.8.3 Fudan-Zhangjiang Liposomal Drug Delivery Device Product and Solutions
2.8.4 Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fudan-Zhangjiang Recent Developments and Future Plans
2.9 Pacira
2.9.1 Pacira Details
2.9.2 Pacira Major Business
2.9.3 Pacira Liposomal Drug Delivery Device Product and Solutions
2.9.4 Pacira Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pacira Recent Developments and Future Plans
2.10 Creative Biolabs
2.10.1 Creative Biolabs Details
2.10.2 Creative Biolabs Major Business
2.10.3 Creative Biolabs Liposomal Drug Delivery Device Product and Solutions
2.10.4 Creative Biolabs Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Creative Biolabs Recent Developments and Future Plans
2.11 Precision NanoSystems Inc.
2.11.1 Precision NanoSystems Inc. Details
2.11.2 Precision NanoSystems Inc. Major Business
2.11.3 Precision NanoSystems Inc. Liposomal Drug Delivery Device Product and Solutions
2.11.4 Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Precision NanoSystems Inc. Recent Developments and Future Plans
2.12 Encapsula NanoSciences LLC
2.12.1 Encapsula NanoSciences LLC Details
2.12.2 Encapsula NanoSciences LLC Major Business
2.12.3 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product and Solutions
2.12.4 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Encapsula NanoSciences LLC Recent Developments and Future Plans
2.13 Avanti Polar Lipids, Inc.
2.13.1 Avanti Polar Lipids, Inc. Details
2.13.2 Avanti Polar Lipids, Inc. Major Business
2.13.3 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product and Solutions
2.13.4 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Avanti Polar Lipids, Inc. Recent Developments and Future Plans
2.14 Viatris Inc.
2.14.1 Viatris Inc. Details
2.14.2 Viatris Inc. Major Business
2.14.3 Viatris Inc. Liposomal Drug Delivery Device Product and Solutions
2.14.4 Viatris Inc. Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Viatris Inc. Recent Developments and Future Plans
2.15 Merrimack Pharmaceuticals, Inc
2.15.1 Merrimack Pharmaceuticals, Inc Details
2.15.2 Merrimack Pharmaceuticals, Inc Major Business
2.15.3 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product and Solutions
2.15.4 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Merrimack Pharmaceuticals, Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liposomal Drug Delivery Device Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Liposomal Drug Delivery Device by Company Revenue
3.2.2 Top 3 Liposomal Drug Delivery Device Players Market Share in 2022
3.2.3 Top 6 Liposomal Drug Delivery Device Players Market Share in 2022
3.3 Liposomal Drug Delivery Device Market: Overall Company Footprint Analysis
3.3.1 Liposomal Drug Delivery Device Market: Region Footprint
3.3.2 Liposomal Drug Delivery Device Market: Company Product Type Footprint
3.3.3 Liposomal Drug Delivery Device Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liposomal Drug Delivery Device Consumption Value and Market Share by Type (2018-2023)
4.2 Global Liposomal Drug Delivery Device Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2023)
5.2 Global Liposomal Drug Delivery Device Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
6.2 North America Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
6.3 North America Liposomal Drug Delivery Device Market Size by Country
6.3.1 North America Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
6.3.2 United States Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
6.3.3 Canada Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
6.3.4 Mexico Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
7.2 Europe Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
7.3 Europe Liposomal Drug Delivery Device Market Size by Country
7.3.1 Europe Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
7.3.2 Germany Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.3 France Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.5 Russia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
7.3.6 Italy Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Liposomal Drug Delivery Device Market Size by Region
8.3.1 Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Region (2018-2029)
8.3.2 China Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.3 Japan Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.4 South Korea Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.5 India Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
8.3.7 Australia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
9.2 South America Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
9.3 South America Liposomal Drug Delivery Device Market Size by Country
9.3.1 South America Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
9.3.2 Brazil Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
9.3.3 Argentina Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Liposomal Drug Delivery Device Market Size by Country
10.3.1 Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Country (2018-2029)
10.3.2 Turkey Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
10.3.4 UAE Liposomal Drug Delivery Device Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Liposomal Drug Delivery Device Market Drivers
11.2 Liposomal Drug Delivery Device Market Restraints
11.3 Liposomal Drug Delivery Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Liposomal Drug Delivery Device Industry Chain
12.2 Liposomal Drug Delivery Device Upstream Analysis
12.3 Liposomal Drug Delivery Device Midstream Analysis
12.4 Liposomal Drug Delivery Device Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Liposomal Drug Delivery Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Liposomal Drug Delivery Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Liposomal Drug Delivery Device Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Liposomal Drug Delivery Device Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Novartis AG Company Information, Head Office, and Major Competitors
Table 6. Novartis AG Major Business
Table 7. Novartis AG Liposomal Drug Delivery Device Product and Solutions
Table 8. Novartis AG Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Novartis AG Recent Developments and Future Plans
Table 10. Luye Pharma Group Company Information, Head Office, and Major Competitors
Table 11. Luye Pharma Group Major Business
Table 12. Luye Pharma Group Liposomal Drug Delivery Device Product and Solutions
Table 13. Luye Pharma Group Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Luye Pharma Group Recent Developments and Future Plans
Table 15. Ipsen Pharma Company Information, Head Office, and Major Competitors
Table 16. Ipsen Pharma Major Business
Table 17. Ipsen Pharma Liposomal Drug Delivery Device Product and Solutions
Table 18. Ipsen Pharma Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Ipsen Pharma Recent Developments and Future Plans
Table 20. Celsion, Inc. Company Information, Head Office, and Major Competitors
Table 21. Celsion, Inc. Major Business
Table 22. Celsion, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 23. Celsion, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Celsion, Inc. Recent Developments and Future Plans
Table 25. Galen Limited Company Information, Head Office, and Major Competitors
Table 26. Galen Limited Major Business
Table 27. Galen Limited Liposomal Drug Delivery Device Product and Solutions
Table 28. Galen Limited Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Galen Limited Recent Developments and Future Plans
Table 30. Astellas Pharma, Inc. Company Information, Head Office, and Major Competitors
Table 31. Astellas Pharma, Inc. Major Business
Table 32. Astellas Pharma, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 33. Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Astellas Pharma, Inc. Recent Developments and Future Plans
Table 35. Acrotech Biopharma, Inc. Company Information, Head Office, and Major Competitors
Table 36. Acrotech Biopharma, Inc. Major Business
Table 37. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 38. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Acrotech Biopharma, Inc. Recent Developments and Future Plans
Table 40. Fudan-Zhangjiang Company Information, Head Office, and Major Competitors
Table 41. Fudan-Zhangjiang Major Business
Table 42. Fudan-Zhangjiang Liposomal Drug Delivery Device Product and Solutions
Table 43. Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Fudan-Zhangjiang Recent Developments and Future Plans
Table 45. Pacira Company Information, Head Office, and Major Competitors
Table 46. Pacira Major Business
Table 47. Pacira Liposomal Drug Delivery Device Product and Solutions
Table 48. Pacira Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pacira Recent Developments and Future Plans
Table 50. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 51. Creative Biolabs Major Business
Table 52. Creative Biolabs Liposomal Drug Delivery Device Product and Solutions
Table 53. Creative Biolabs Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Creative Biolabs Recent Developments and Future Plans
Table 55. Precision NanoSystems Inc. Company Information, Head Office, and Major Competitors
Table 56. Precision NanoSystems Inc. Major Business
Table 57. Precision NanoSystems Inc. Liposomal Drug Delivery Device Product and Solutions
Table 58. Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Precision NanoSystems Inc. Recent Developments and Future Plans
Table 60. Encapsula NanoSciences LLC Company Information, Head Office, and Major Competitors
Table 61. Encapsula NanoSciences LLC Major Business
Table 62. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product and Solutions
Table 63. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Encapsula NanoSciences LLC Recent Developments and Future Plans
Table 65. Avanti Polar Lipids, Inc. Company Information, Head Office, and Major Competitors
Table 66. Avanti Polar Lipids, Inc. Major Business
Table 67. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 68. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Avanti Polar Lipids, Inc. Recent Developments and Future Plans
Table 70. Viatris Inc. Company Information, Head Office, and Major Competitors
Table 71. Viatris Inc. Major Business
Table 72. Viatris Inc. Liposomal Drug Delivery Device Product and Solutions
Table 73. Viatris Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Viatris Inc. Recent Developments and Future Plans
Table 75. Merrimack Pharmaceuticals, Inc Company Information, Head Office, and Major Competitors
Table 76. Merrimack Pharmaceuticals, Inc Major Business
Table 77. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product and Solutions
Table 78. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Merrimack Pharmaceuticals, Inc Recent Developments and Future Plans
Table 80. Global Liposomal Drug Delivery Device Revenue (USD Million) by Players (2018-2023)
Table 81. Global Liposomal Drug Delivery Device Revenue Share by Players (2018-2023)
Table 82. Breakdown of Liposomal Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Liposomal Drug Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Liposomal Drug Delivery Device Players
Table 85. Liposomal Drug Delivery Device Market: Company Product Type Footprint
Table 86. Liposomal Drug Delivery Device Market: Company Product Application Footprint
Table 87. Liposomal Drug Delivery Device New Market Entrants and Barriers to Market Entry
Table 88. Liposomal Drug Delivery Device Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Liposomal Drug Delivery Device Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Liposomal Drug Delivery Device Consumption Value Share by Type (2018-2023)
Table 91. Global Liposomal Drug Delivery Device Consumption Value Forecast by Type (2024-2029)
Table 92. Global Liposomal Drug Delivery Device Consumption Value by Application (2018-2023)
Table 93. Global Liposomal Drug Delivery Device Consumption Value Forecast by Application (2024-2029)
Table 94. North America Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Liposomal Drug Delivery Device Raw Material
Table 125. Key Suppliers of Liposomal Drug Delivery Device Raw Materials
Table 1. Global Liposomal Drug Delivery Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Liposomal Drug Delivery Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Liposomal Drug Delivery Device Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Liposomal Drug Delivery Device Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Novartis AG Company Information, Head Office, and Major Competitors
Table 6. Novartis AG Major Business
Table 7. Novartis AG Liposomal Drug Delivery Device Product and Solutions
Table 8. Novartis AG Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Novartis AG Recent Developments and Future Plans
Table 10. Luye Pharma Group Company Information, Head Office, and Major Competitors
Table 11. Luye Pharma Group Major Business
Table 12. Luye Pharma Group Liposomal Drug Delivery Device Product and Solutions
Table 13. Luye Pharma Group Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Luye Pharma Group Recent Developments and Future Plans
Table 15. Ipsen Pharma Company Information, Head Office, and Major Competitors
Table 16. Ipsen Pharma Major Business
Table 17. Ipsen Pharma Liposomal Drug Delivery Device Product and Solutions
Table 18. Ipsen Pharma Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Ipsen Pharma Recent Developments and Future Plans
Table 20. Celsion, Inc. Company Information, Head Office, and Major Competitors
Table 21. Celsion, Inc. Major Business
Table 22. Celsion, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 23. Celsion, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Celsion, Inc. Recent Developments and Future Plans
Table 25. Galen Limited Company Information, Head Office, and Major Competitors
Table 26. Galen Limited Major Business
Table 27. Galen Limited Liposomal Drug Delivery Device Product and Solutions
Table 28. Galen Limited Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Galen Limited Recent Developments and Future Plans
Table 30. Astellas Pharma, Inc. Company Information, Head Office, and Major Competitors
Table 31. Astellas Pharma, Inc. Major Business
Table 32. Astellas Pharma, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 33. Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Astellas Pharma, Inc. Recent Developments and Future Plans
Table 35. Acrotech Biopharma, Inc. Company Information, Head Office, and Major Competitors
Table 36. Acrotech Biopharma, Inc. Major Business
Table 37. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 38. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Acrotech Biopharma, Inc. Recent Developments and Future Plans
Table 40. Fudan-Zhangjiang Company Information, Head Office, and Major Competitors
Table 41. Fudan-Zhangjiang Major Business
Table 42. Fudan-Zhangjiang Liposomal Drug Delivery Device Product and Solutions
Table 43. Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Fudan-Zhangjiang Recent Developments and Future Plans
Table 45. Pacira Company Information, Head Office, and Major Competitors
Table 46. Pacira Major Business
Table 47. Pacira Liposomal Drug Delivery Device Product and Solutions
Table 48. Pacira Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pacira Recent Developments and Future Plans
Table 50. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 51. Creative Biolabs Major Business
Table 52. Creative Biolabs Liposomal Drug Delivery Device Product and Solutions
Table 53. Creative Biolabs Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Creative Biolabs Recent Developments and Future Plans
Table 55. Precision NanoSystems Inc. Company Information, Head Office, and Major Competitors
Table 56. Precision NanoSystems Inc. Major Business
Table 57. Precision NanoSystems Inc. Liposomal Drug Delivery Device Product and Solutions
Table 58. Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Precision NanoSystems Inc. Recent Developments and Future Plans
Table 60. Encapsula NanoSciences LLC Company Information, Head Office, and Major Competitors
Table 61. Encapsula NanoSciences LLC Major Business
Table 62. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product and Solutions
Table 63. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Encapsula NanoSciences LLC Recent Developments and Future Plans
Table 65. Avanti Polar Lipids, Inc. Company Information, Head Office, and Major Competitors
Table 66. Avanti Polar Lipids, Inc. Major Business
Table 67. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product and Solutions
Table 68. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Avanti Polar Lipids, Inc. Recent Developments and Future Plans
Table 70. Viatris Inc. Company Information, Head Office, and Major Competitors
Table 71. Viatris Inc. Major Business
Table 72. Viatris Inc. Liposomal Drug Delivery Device Product and Solutions
Table 73. Viatris Inc. Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Viatris Inc. Recent Developments and Future Plans
Table 75. Merrimack Pharmaceuticals, Inc Company Information, Head Office, and Major Competitors
Table 76. Merrimack Pharmaceuticals, Inc Major Business
Table 77. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product and Solutions
Table 78. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Merrimack Pharmaceuticals, Inc Recent Developments and Future Plans
Table 80. Global Liposomal Drug Delivery Device Revenue (USD Million) by Players (2018-2023)
Table 81. Global Liposomal Drug Delivery Device Revenue Share by Players (2018-2023)
Table 82. Breakdown of Liposomal Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Liposomal Drug Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Liposomal Drug Delivery Device Players
Table 85. Liposomal Drug Delivery Device Market: Company Product Type Footprint
Table 86. Liposomal Drug Delivery Device Market: Company Product Application Footprint
Table 87. Liposomal Drug Delivery Device New Market Entrants and Barriers to Market Entry
Table 88. Liposomal Drug Delivery Device Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Liposomal Drug Delivery Device Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Liposomal Drug Delivery Device Consumption Value Share by Type (2018-2023)
Table 91. Global Liposomal Drug Delivery Device Consumption Value Forecast by Type (2024-2029)
Table 92. Global Liposomal Drug Delivery Device Consumption Value by Application (2018-2023)
Table 93. Global Liposomal Drug Delivery Device Consumption Value Forecast by Application (2024-2029)
Table 94. North America Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Liposomal Drug Delivery Device Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Liposomal Drug Delivery Device Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Liposomal Drug Delivery Device Raw Material
Table 125. Key Suppliers of Liposomal Drug Delivery Device Raw Materials
LIST OF FIGURES
Figure 1. Liposomal Drug Delivery Device Picture
Figure 2. Global Liposomal Drug Delivery Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Liposomal Drug Delivery Device Consumption Value Market Share by Type in 2022
Figure 4. Stealth Liposome Technology
Figure 5. NonPEGylated Liposome Technology
Figure 6. DepoFoam Liposome Technology
Figure 7. Global Liposomal Drug Delivery Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Liposomal Drug Delivery Device Consumption Value Market Share by Application in 2022
Figure 9. Fungal Diseases Picture
Figure 10. Cancer Therapy Picture
Figure 11. Pain Management Picture
Figure 12. Viral Vaccines Picture
Figure 13. Photodynamic Therapy Picture
Figure 14. Global Liposomal Drug Delivery Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Liposomal Drug Delivery Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Liposomal Drug Delivery Device Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Liposomal Drug Delivery Device Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Liposomal Drug Delivery Device Consumption Value Market Share by Region in 2022
Figure 19. North America Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Liposomal Drug Delivery Device Revenue Share by Players in 2022
Figure 25. Liposomal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Liposomal Drug Delivery Device Market Share in 2022
Figure 27. Global Top 6 Players Liposomal Drug Delivery Device Market Share in 2022
Figure 28. Global Liposomal Drug Delivery Device Consumption Value Share by Type (2018-2023)
Figure 29. Global Liposomal Drug Delivery Device Market Share Forecast by Type (2024-2029)
Figure 30. Global Liposomal Drug Delivery Device Consumption Value Share by Application (2018-2023)
Figure 31. Global Liposomal Drug Delivery Device Market Share Forecast by Application (2024-2029)
Figure 32. North America Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 42. France Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Liposomal Drug Delivery Device Consumption Value Market Share by Region (2018-2029)
Figure 49. China Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 52. India Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 66. Liposomal Drug Delivery Device Market Drivers
Figure 67. Liposomal Drug Delivery Device Market Restraints
Figure 68. Liposomal Drug Delivery Device Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Liposomal Drug Delivery Device in 2022
Figure 71. Manufacturing Process Analysis of Liposomal Drug Delivery Device
Figure 72. Liposomal Drug Delivery Device Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Liposomal Drug Delivery Device Picture
Figure 2. Global Liposomal Drug Delivery Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Liposomal Drug Delivery Device Consumption Value Market Share by Type in 2022
Figure 4. Stealth Liposome Technology
Figure 5. NonPEGylated Liposome Technology
Figure 6. DepoFoam Liposome Technology
Figure 7. Global Liposomal Drug Delivery Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Liposomal Drug Delivery Device Consumption Value Market Share by Application in 2022
Figure 9. Fungal Diseases Picture
Figure 10. Cancer Therapy Picture
Figure 11. Pain Management Picture
Figure 12. Viral Vaccines Picture
Figure 13. Photodynamic Therapy Picture
Figure 14. Global Liposomal Drug Delivery Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Liposomal Drug Delivery Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Liposomal Drug Delivery Device Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Liposomal Drug Delivery Device Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Liposomal Drug Delivery Device Consumption Value Market Share by Region in 2022
Figure 19. North America Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Liposomal Drug Delivery Device Revenue Share by Players in 2022
Figure 25. Liposomal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Liposomal Drug Delivery Device Market Share in 2022
Figure 27. Global Top 6 Players Liposomal Drug Delivery Device Market Share in 2022
Figure 28. Global Liposomal Drug Delivery Device Consumption Value Share by Type (2018-2023)
Figure 29. Global Liposomal Drug Delivery Device Market Share Forecast by Type (2024-2029)
Figure 30. Global Liposomal Drug Delivery Device Consumption Value Share by Application (2018-2023)
Figure 31. Global Liposomal Drug Delivery Device Market Share Forecast by Application (2024-2029)
Figure 32. North America Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 42. France Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Liposomal Drug Delivery Device Consumption Value Market Share by Region (2018-2029)
Figure 49. China Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 52. India Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Liposomal Drug Delivery Device Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Liposomal Drug Delivery Device Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Liposomal Drug Delivery Device Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Liposomal Drug Delivery Device Consumption Value (2018-2029) & (USD Million)
Figure 66. Liposomal Drug Delivery Device Market Drivers
Figure 67. Liposomal Drug Delivery Device Market Restraints
Figure 68. Liposomal Drug Delivery Device Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Liposomal Drug Delivery Device in 2022
Figure 71. Manufacturing Process Analysis of Liposomal Drug Delivery Device
Figure 72. Liposomal Drug Delivery Device Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
